{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T04:19:46Z","timestamp":1793679586122,"version":"4.5.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:00:00Z","timestamp":1726099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:00:00Z","timestamp":1726099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>This retrospective analysis evaluates the treatment success of \u201cDefocus Incorporated Multiple Segments\u201d (DIMS) spectacle lenses in a real-life clinical setting in Germany.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Materials and methods<\/jats:title>\n                <jats:p>Axial length (AL) and objective refraction of 166 eyes treated with DIMS at baseline and 12-month follow-up were analyzed. Annual AL growth rate within the range of physiological growth rate was considered a successful treatment. Myopia progression of \u2265 -0.5 D\/yr accounted as treatment success. Differences in percentages of treatment success of subgroups depending on baseline AL and age against treatment success of the total population were investigated.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Considering all eyes, treatment success regarding AL growth and myopia progression was achieved in 46% and 65%, respectively. Male eyes with moderate AL showed treatment success in a higher proportion (73%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01; 89%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01); eyes with high AL showed treatment success in a lower proportion (25%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01; 51%, n.s.). Female eyes showed the same trend but without statistical significance (moderate AL: 49%; 68%; high AL: 40%; 62%). Younger children showed treatment success in a lower proportion (male: 11%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01; 38%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05; female: 25%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01; 42%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01). Older children showed treatment success in a higher proportion (male: 60%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05; 78% <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05; female: 53%, n.s.; 77% <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Eyes with moderate baseline AL and of older children showed treatment success after 12 months of DIMS treatment. Eyes with a high baseline AL and of younger children showed treatment success in a smaller proportion, therefore combination treatment should be considered. In future studies, males and females should be assessed separately.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12886-024-03666-5","type":"journal-article","created":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T07:04:37Z","timestamp":1726124677000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Effect of defocus incorporated multiple segments (DIMS) spectacle lenses on myopia progression in children: a retrospective analysis in a German real-life clinical setting"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9005-172X","authenticated-orcid":false,"given":"Birte","family":"Neller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9488-6938","authenticated-orcid":false,"given":"Kai","family":"Neller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7791-532X","authenticated-orcid":false,"given":"Hartmut","family":"Schwahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0585-7818","authenticated-orcid":false,"given":"Ann-Isabel","family":"Mattern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0698-7163","authenticated-orcid":false,"given":"Machteld","family":"Devenijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9175-6177","authenticated-orcid":false,"given":"Achim","family":"Langenbucher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9701-8204","authenticated-orcid":false,"given":"Berthold","family":"Seitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5006-7420","authenticated-orcid":false,"given":"Hakan","family":"Kaymak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,12]]},"reference":[{"issue":"6","key":"3666_CR1","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1001\/jamaophthalmol.2015.0471","volume":"133","author":"K Zadnik","year":"2015","unstructured":"Zadnik K, Sinnott LT, Cotter SA, et al. Prediction of juvenile-onset myopia. JAMA Ophthalmol. 2015;133(6):683\u20139.","journal-title":"JAMA Ophthalmol"},{"issue":"5","key":"3666_CR2","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/j.1475-1313.2005.00298.x","volume":"25","author":"S-M Saw","year":"2005","unstructured":"Saw S-M, Gazzard G, Shih-Yen EC, Chua W-H. Myopia and associated pathological complications. Ophthalmic Physiological Optics: J Br Coll Ophthalmic Opticians (Optometrists). 2005;25(5):381\u201391.","journal-title":"Ophthalmic Physiological Optics: J Br Coll Ophthalmic Opticians (Optometrists)"},{"issue":"6","key":"3666_CR3","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.preteyeres.2012.06.004","volume":"31","author":"DI Flitcroft","year":"2012","unstructured":"Flitcroft DI. The complex interactions of retinal, optical and environmental factors in myopia aetiology. Prog Retin Eye Res. 2012;31(6):622\u201360.","journal-title":"Prog Retin Eye Res"},{"key":"3666_CR4","doi-asserted-by":"crossref","unstructured":"Wong TY, Ferreira A, Hughes R, Carter G, Mitchell P. Epidemiology and disease burden of pathologic myopia and myopic choroidal neovascularization: an evidence-based systematic review. American journal of ophthalmology. 2014;157(1):9\u201325.e12. Published October 5, 2013.","DOI":"10.1016\/j.ajo.2013.08.010"},{"issue":"5","key":"3666_CR5","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.ophtha.2016.01.006","volume":"123","author":"BA Holden","year":"2016","unstructured":"Holden BA, Fricke TR, Wilson DA, et al. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology. 2016;123(5):1036\u201342. Published February 11, 2016.","journal-title":"Ophthalmology"},{"issue":"7","key":"3666_CR6","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/j.ophtha.2015.03.018","volume":"122","author":"KM Williams","year":"2015","unstructured":"Williams KM, Bertelsen G, Cumberland P, et al. Increasing prevalence of myopia in Europe and the impact of education. Ophthalmology. 2015;122(7):1489\u201397. Published May 13, 2015.","journal-title":"Ophthalmology"},{"issue":"4","key":"3666_CR7","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s10654-015-0010-0","volume":"30","author":"KM Williams","year":"2015","unstructured":"Williams KM, Verhoeven VJM, Cumberland P, et al. Prevalence of refractive error in Europe: the European Eye Epidemiology (E(3)) Consortium. Eur J Epidemiol. 2015;30(4):305\u201315. Published March 18, 2015.","journal-title":"Eur J Epidemiol"},{"key":"3666_CR8","doi-asserted-by":"crossref","unstructured":"Ang M, Wong TY. Updates on Myopia: A Clinical Perspective, 1st ed. 2020. Singapore: Springer Singapore; Imprint: Springer, 2020, 1st ed. 2020.","DOI":"10.1007\/978-981-13-8491-2"},{"key":"3666_CR9","doi-asserted-by":"crossref","unstructured":"Carl\u00e0 MM, Boselli F, Giannuzzi F et al. Overview on Defocus Incorporated Multiple Segments Lenses: A Novel Perspective in Myopia Progression Management. Vision (Basel, Switzerland). 2022;6(2). Published April 2, 2022.","DOI":"10.3390\/vision6020020"},{"issue":"3","key":"3666_CR10","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1136\/bjophthalmol-2018-313739","volume":"104","author":"CSY Lam","year":"2020","unstructured":"Lam CSY, Tang WC, Tse DY, et al. Defocus Incorporated multiple segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomised clinical trial. Br J Ophthalmol. 2020;104(3):363\u20138. Published May 29, 2019.","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"3666_CR11","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/opo.12725","volume":"40","author":"M Jaskulski","year":"2020","unstructured":"Jaskulski M, Singh NK, Bradley A, Kollbaum PS. Optical and imaging properties of a novel multi-segment spectacle lens designed to slow myopia progression. Ophthalmic Physiological Optics: J Br Coll Ophthalmic Opticians (Optometrists). 2020;40(5):549\u201356. Published August 18, 2020.","journal-title":"Ophthalmic Physiological Optics: J Br Coll Ophthalmic Opticians (Optometrists)"},{"key":"3666_CR12","doi-asserted-by":"crossref","unstructured":"Gantes-Nu\u00f1ez J, Jaskulski M, L\u00f3pez-Gil N, Kollbaum PS. Optical characterisation of two novel myopia control spectacle lenses. Ophthalmic & physiological optics: the journal of the British College of Ophthalmic Opticians (Optometrists) 2023. Published February 4, 2023.","DOI":"10.1111\/opo.13098"},{"key":"3666_CR13","doi-asserted-by":"crossref","unstructured":"Lam CS, Tang WC, Lee PH et al. Myopia control effect of Defocus incorporated multiple segments (DIMS) spectacle lens in Chinese children: results of a 3-year follow-up study. Br J Ophthalmol 2021 Published March 17, 2021.","DOI":"10.1136\/bjophthalmol-2020-317664"},{"key":"3666_CR14","doi-asserted-by":"crossref","unstructured":"Lam CSY, Tang WC, Zhang HY et al. Long-term myopia control effect and safety in children wearing DIMS spectacle lenses for 6 years. Scientific reports. 2023;13(1):5475. Published April 4, 2023.","DOI":"10.1038\/s41598-023-32700-7"},{"issue":"12","key":"3666_CR15","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1007\/s00347-021-01452-y","volume":"118","author":"H Kaymak","year":"2021","unstructured":"Kaymak H, Graff B, Neller K, Langenbucher A, Seitz B, Schwahn H. Myopietherapie und Prophylaxe Mit \u201eDefocus Incorporated multiple Segments-Brillengl\u00e4sern. Der Ophthalmologe: Z Der Deutschen Ophthalmologischen Gesellschaft. 2021;118(12):1280\u20136. Published July 8, 2021.","journal-title":"Der Ophthalmologe: Z Der Deutschen Ophthalmologischen Gesellschaft"},{"key":"3666_CR16","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.ajo.2019.12.002","volume":"211","author":"Y Lu","year":"2020","unstructured":"Lu Y, Lin Z, Wen L, et al. The Adaptation and Acceptance of Defocus Incorporated Multiple Segment Lens for Chinese Children. Am J Ophthalmol. 2020;211:207\u201316. Published December 13, 2019. https:\/\/pubmed.ncbi.nlm.nih.gov\/31837317\/","journal-title":"Am J Ophthalmol"},{"key":"3666_CR17","doi-asserted-by":"crossref","unstructured":"Lam CSY, Tang WC, Qi H et al. Effect of Defocus Incorporated Multiple Segments Spectacle Lens Wear on Visual Function in Myopic Chinese Children. Translational vision science & technology. 2020;9(9):11. Published August 5, 2020.","DOI":"10.1167\/tvst.9.9.11"},{"issue":"1","key":"3666_CR18","doi-asserted-by":"publisher","first-page":"e000971","DOI":"10.1136\/bmjophth-2022-000971","volume":"7","author":"H Kaymak","year":"2022","unstructured":"Kaymak H, Neller K, Sch\u00fctz S, et al. Vision tests on spectacle lenses and contact lenses for optical myopia correction: a pilot study. BMJ open Ophthalmol. 2022;7(1):e000971. Published April 5, 2022.","journal-title":"BMJ open Ophthalmol"},{"issue":"10","key":"3666_CR19","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1055\/a-1930-7116","volume":"239","author":"H Kaymak","year":"2022","unstructured":"Kaymak H, Mattern A-I, Graff B, et al. Sicherheit Von Brillengl\u00e4sern Mit DIMS-Technologie Und Atropin in Der Kombinationstherapie Der Myopieprogression. Klin Monatsbl Augenheilkd. 2022;239(10):1197\u2013205. Published August 25, 2022.","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"3666_CR20","doi-asserted-by":"publisher","first-page":"100923","DOI":"10.1016\/j.preteyeres.2020.100923","volume":"83","author":"NA Brennan","year":"2021","unstructured":"Brennan NA, Toubouti YM, Cheng X, Bullimore MA. Efficacy in myopia control. Prog Retin Eye Res. 2021;83:100923. Published November 27, 2020.","journal-title":"Prog Retin Eye Res"},{"issue":"3","key":"3666_CR21","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/opo.13094","volume":"43","author":"JJ Rozema","year":"2023","unstructured":"Rozema JJ. Refractive development I: biometric changes during emmetropisation. Ophthalmic & physiological optics. J Br Coll Ophthalmic Opticians (Optometrists). 2023;43(3):347\u201367. Published February 5, 2023.","journal-title":"J Br Coll Ophthalmic Opticians (Optometrists)"},{"issue":"3","key":"3666_CR22","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1111\/opo.12812","volume":"41","author":"P Chamberlain","year":"2021","unstructured":"Chamberlain P, La Lazon de Jara P, Arumugam B, Bullimore MA. Axial length targets for myopia control. Ophthalmic Physiological Optics: J Br Coll Ophthalmic Opticians (Optometrists). 2021;41(3):523\u201331. Published May 5, 2021.","journal-title":"Ophthalmic Physiological Optics: J Br Coll Ophthalmic Opticians (Optometrists)"},{"issue":"6","key":"3666_CR23","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1167\/iovs.64.6.7","volume":"64","author":"P Sankaridurg","year":"2023","unstructured":"Sankaridurg P, Berntsen DA, Bullimore MA, et al. IMI 2023 Digest. Invest Ophthalmol Vis Sci. 2023;64(6):7.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3666_CR24","doi-asserted-by":"crossref","unstructured":"Bullimore MA, Brennan NA, Flitcroft DI. The future of clinical trials of myopia control. Ophthalmic & physiological optics: the journal of the British College of Ophthalmic Opticians (Optometrists). 2023;43(3):525\u2013533. Published March 10, 2023.","DOI":"10.1111\/opo.13120"},{"key":"3666_CR25","doi-asserted-by":"crossref","unstructured":"Tideman JWL, Polling JR, Vingerling JR, et al. Axial length growth and the risk of developing myopia in European children. Acta Ophthalmol. 2018;96(3):301\u20139. Published December 19, 2017.","DOI":"10.1111\/aos.13603"},{"issue":"2","key":"3666_CR26","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/opo.12676","volume":"40","author":"C Klaver","year":"2020","unstructured":"Klaver C, Polling JR. Myopia management in the Netherlands. Ophthalmic Physiological Optics: J Br Coll Ophthalmic Opticians (Optometrists). 2020;40(2):230\u201340.","journal-title":"Ophthalmic Physiological Optics: J Br Coll Ophthalmic Opticians (Optometrists)"},{"key":"3666_CR27","doi-asserted-by":"crossref","unstructured":"Truckenbrod C, Meigen C, Brandt M et al. Longitudinal analysis of axial length growth in a German cohort of healthy children and adolescents. Ophthalmic & physiological optics: the journal of the British College of Ophthalmic Opticians (Optometrists). 2021. Published April 1, 2021.","DOI":"10.1111\/opo.12817"},{"key":"3666_CR28","doi-asserted-by":"crossref","unstructured":"Yam JC, Zhang XJ, Zhang Y et al. Three-Year Clinical Trial of Low-Concentration Atropine for Myopia Progression (LAMP) Study: Continued Versus Washout: Phase 3 Report. Ophthalmology. 2022;129(3):308\u2013321. Published October 7, 2021.","DOI":"10.1016\/j.ophtha.2021.10.002"},{"issue":"8","key":"3666_CR29","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1097\/OPX.0000000000001410","volume":"96","author":"P Chamberlain","year":"2019","unstructured":"Chamberlain P, Peixoto-de-Matos SC, Logan NS, Ngo C, Jones D, Young G. A 3-year Randomized Clinical Trial of MiSight lenses for Myopia Control. Optometry Vis Science: Official Publication Am Acad Optometry. 2019;96(8):556\u201367.","journal-title":"Optometry Vis Science: Official Publication Am Acad Optometry"},{"issue":"6","key":"3666_CR30","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1001\/jama.2020.10834","volume":"324","author":"JJ Walline","year":"2020","unstructured":"Walline JJ, Walker MK, Mutti DO, et al. Effect of high add power, Medium Add Power, or single-vision contact lenses on myopia progression in children: the BLINK Randomized Clinical Trial. JAMA. 2020;324(6):571\u201380.","journal-title":"JAMA"},{"key":"3666_CR31","doi-asserted-by":"crossref","unstructured":"Paun\u00e9 J, Fonts S, Rodr\u00edguez L, Queir\u00f3s A. The role of back Optic Zone Diameter in Myopia Control with Orthokeratology lenses. J Clin Med 2021;10(2). Published January 18, 2021.","DOI":"10.3390\/jcm10020336"},{"issue":"Suppl 1","key":"3666_CR32","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00347-021-01427-z","volume":"119","author":"H Kaymak","year":"2022","unstructured":"Kaymak H, Neller K, Graff B, et al. Optometrische Schulreihenuntersuchungen: Erste Epidemiologische Daten Von Kindern und Jugendlichen Der 5. Bis 7. Klasse. Ophthalmologe. 2022;119(Suppl 1):33\u201340. Published June 10, 2021.","journal-title":"Ophthalmologe"},{"key":"3666_CR33","doi-asserted-by":"crossref","unstructured":"Mattern A-I, Neller K, Devenijn M et al. A comparison of optical biometers used in children for myopia control. Klinische Monatsblatter fur Augenheilkunde 2023. Published June 26, 2023.","DOI":"10.1055\/a-2117-9335"},{"issue":"12","key":"3666_CR34","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1136\/bjophthalmol-2016-309299","volume":"101","author":"C-C Hsu","year":"2017","unstructured":"Hsu C-C, Huang N, Lin P-Y, et al. Risk factors for myopia progression in second-grade primary school children in Taipei: a population-based cohort study. Br J Ophthalmol. 2017;101(12):1611\u20137. Published March 18, 2017.","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"3666_CR35","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ophtha.2011.07.031","volume":"119","author":"A Chia","year":"2012","unstructured":"Chia A, Chua W-H, Cheung Y-B, et al. Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (atropine for the treatment of myopia 2). Ophthalmology. 2012;119(2):347\u201354. Published October 2, 2011.","journal-title":"Ophthalmology"},{"issue":"7","key":"3666_CR36","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1167\/iovs.04-0945","volume":"46","author":"LA Jones","year":"2005","unstructured":"Jones LA, Mitchell GL, Mutti DO, Hayes JR, Moeschberger ML, Zadnik K. Comparison of ocular component growth curves among refractive error groups in children. Investig Ophthalmol Vis Sci. 2005;46(7):2317\u201327.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"3666_CR37","unstructured":"N\u00e9meth J, Tapaszt\u00f3 B, Aclimandos WA et al. Update and guidance on management of myopia. European Society of Ophthalmology in cooperation with International Myopia Institute. European journal of ophthalmology. 2021;31(3):853\u2013883. Published March 5, 2021."},{"key":"3666_CR38","doi-asserted-by":"crossref","unstructured":"Rose KA, Morgan IG, Smith W, Burlutsky G, Mitchell P, Saw S-M. Myopia, lifestyle, and schooling in students of Chinese ethnicity in Singapore and Sydney. Archives of ophthalmology (Chicago, Ill.: 1960) 2008;126(4):527\u2013530.","DOI":"10.1001\/archopht.126.4.527"},{"key":"3666_CR39","doi-asserted-by":"crossref","unstructured":"Ip JM, Huynh SC, Robaei D et al. Ethnic differences in refraction and ocular biometry in a population-based sample of 11-15-year-old Australian children. Eye (London, England). 2008;22(5):649\u2013656. Published February 2, 2007.","DOI":"10.1038\/sj.eye.6702701"},{"key":"3666_CR40","doi-asserted-by":"crossref","unstructured":"Bullimore MA, Brennan NA. Juvenile-onset myopia-who to treat and how to evaluate success. Eye (London, England). 2023. Published September 14, 2023.","DOI":"10.1038\/s41433-023-02722-6"},{"issue":"2","key":"3666_CR41","doi-asserted-by":"publisher","first-page":"e430","DOI":"10.1111\/aos.14980","volume":"100","author":"O P\u00e4rssinen","year":"2022","unstructured":"P\u00e4rssinen O, Kauppinen M. Associations of near work time, watching TV, outdoors time, and parents\u2019 myopia with myopia among school children based on 38-year-old historical data. Acta Ophthalmol. 2022;100(2):e430\u20138. Published July 21, 2021.","journal-title":"Acta Ophthalmol"},{"issue":"3","key":"3666_CR42","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/opo.12045","volume":"33","author":"AN French","year":"2013","unstructured":"French AN, Morgan IG, Mitchell P, Rose KA. Patterns of myopigenic activities with age, gender and ethnicity in Sydney schoolchildren. Ophthalmic Physiological Optics: J Br Coll Ophthalmic Opticians (Optometrists). 2013;33(3):318\u201328. Published March 4, 2013.","journal-title":"Ophthalmic Physiological Optics: J Br Coll Ophthalmic Opticians (Optometrists)"},{"key":"3666_CR43","doi-asserted-by":"crossref","unstructured":"Xiong S, Sankaridurg P, Naduvilath T et al. Time spent in outdoor activities in relation to myopia prevention and control: a meta-analysis and systematic review. Acta ophthalmologica. 2017;95(6):551\u2013566. Published March 2, 2017.","DOI":"10.1111\/aos.13403"},{"issue":"5","key":"3666_CR44","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1007\/s10384-018-0608-3","volume":"62","author":"N Kinoshita","year":"2018","unstructured":"Kinoshita N, Konno Y, Hamada N, Kanda Y, Shimmura-Tomita M, Kakehashi A. Additive effects of orthokeratology and atropine 0.01% ophthalmic solution in slowing axial elongation in children with myopia: first year results. Jpn J Ophthalmol. 2018;62(5):544\u201353. Published July 4, 2018.","journal-title":"Jpn J Ophthalmol"},{"issue":"1","key":"3666_CR45","doi-asserted-by":"publisher","first-page":"22311","DOI":"10.1038\/s41598-022-25599-z","volume":"12","author":"Z Huang","year":"2022","unstructured":"Huang Z, Chen X-F, He T, Tang Y, Du C-X. Synergistic effects of defocus-incorporated multiple segments and atropine in slowing the progression of myopia. Sci Rep. 2022;12(1):22311. Published December 24, 2022.","journal-title":"Sci Rep"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-024-03666-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-024-03666-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-024-03666-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T07:08:43Z","timestamp":1726124923000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-024-03666-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,12]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3666"],"URL":"https:\/\/doi.org\/10.1186\/s12886-024-03666-5","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,12]]},"assertion":[{"value":"3 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The need for ethical approval was waived by the ethics committee of \u00c4rztekammer Nordrhein for this kind of retrospective, descriptive, non-interventional study. All procedures performed were in accordance with the Helsinki Declaration of 1964 and its later amendments or comparable ethical standards. The data analyzed were routinely collected during treatment, and no additional interventions or examinations were performed. Informed consent was obtained from the legal guardians of all individual participants included in the study to analyze the routinely collected data anonymously for scientific purposes.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"HK was a consultant for Hoya Lens Deutschland, has received expense allowances for speaker activities and speaker honoraria from Hoya Lens Deutschland and Hoya Holdings N.V. outside the scope of the submitted work. BN and AM have received expense allowances for speaker activities and speaker honoraria from Hoya Holdings N.V. outside the scope of the submitted work. The remaining authors (KN, HS, MD, AL, BS) have no competing interests to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"403"}}